Depression in Parkinson's disease
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Depression in Parkinson's disease (PD) is a common complication, with a major impact on quality of life. Failure to recognize and treat depression can lead to premature and inappropriate discontinuation of antiparkinsonian therapies. Cited frequency for depression in PD varies between 2.7 and 70%. Methodological differences account for much of the disparity. The aetiology of depression in PD is complex, with ‘tonic’ (slowly changing and persistent) and ‘phasic’ (short‐lived and fluctuating) components. Both depression and anxiety may predate the onset of the motor disorder by some years. Hedonistic homeostatic dysregulation is a cyclical mood disorder associated with excessive intake of dopaminergic therapies, inappropriate for the motor state. Negative affective symptoms occur on attempted reduction of medication, reinforcing the abnormal medication pattern. The Montgomery‐Åsberg Depression Rating Scale and the Hamilton Rating Scale for Depression have good diagnostic sensitivity and specificity for assessing depression in PD. There is a dearth of sizeable, placebo‐controlled studies for evaluating drug treatment of depression in PD. Dopaminergic drugs have variable antidepressant properties. Selective serotonin reuptake inhibitors are currently the most commonly prescribed group of antidepressants in the depressed PD patient. Depression in the PD patient may be associated with a more rapid deterioration in cognitive and motor functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Therapeutic application of repetitive transcranial magnetic stimulation: a review
Wassermann, E. M., & Lisanby, S. H. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00585-5 · Cited by 601
Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease
Mayberg, H. S., Starkstein, S. E., Sadzot, B., Preziosi, T., Andrezejewski, P. L., Dannals, R. F., Wagner, H. N., & Robinson, R. G. (1990) · Annals of Neurology · doi:10.1002/ana.410280111 · Cited by 412
Parkinson's disease with depression: A possible subgroup of idiopathic parkinsonism
Santamaria, J., Tolosa, E., & Valles, A. (1986) · Neurology · doi:10.1212/wnl.36.8.1130 · Cited by 233
Depression in Parkinson's Disease: A Positron Emission Study
Ring, H. A., Bench, C. J., Trimble, M. R., Brooks, D. J., Frackowiak, R. S. J., & Dolan, R. J. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.165.3.333 · Cited by 219
Maricle, R. A., Nutt, J. G., Valentine, R. J., & Carter, J. H. (1995) · Neurology · doi:10.1212/wnl.45.9.1757 · Cited by 197
Hobson, P. (1999) · Age and Ageing · doi:10.1093/ageing/28.4.341 · Cited by 152
Sleep Disorders in Patients with Parkinson??s Disease: Epidemiology and Management
Larsen, J. P., & Tandberg, E. (2001) · CNS Drugs · doi:10.2165/00023210-200115040-00002 · Cited by 102
Research works printed but not linked: 107
- 10.1016/S0079-6123(08)62678-3 · DOI · Paper page
- 10.1136/bmj.320.7245.1287 · DOI · Paper page
- 10.1111/j.1600-0404.1980.tb03028.x · DOI · Paper page
- 10.1097/00002826-199720001-00006 · DOI · Paper page
- 10.1002/(SICI)1099-1166(199910)14:10<866::AID-GPS38>3.0.CO;2-Z · DOI · Paper page
- 10.1176/ajp.134.2.191 · DOI · Paper page
- Beekman ATF, 1999, Mental Dysfunction in Parkinson's Disease, 263
- 10.1056/NEJM199905133401905 · DOI · Paper page
- 10.1007/s004150050541 · DOI
- 10.1111/j.1600-0404.1983.tb01522.x · DOI · Paper page
- Brown R, 1995, Depression in Parkinson's disease: a psychosocial viewpoint, Adv Neurol, 65, 61
- 10.1017/S0033291700001872 · DOI · Paper page
- 10.1001/archneur.1989.00520450025014 · DOI · Paper page
- Caley CF, 1992, Does fluoxetine exacerbate Parkinson's disease?, J Clin Psychiatry, 53, 278
- 10.1136/jnnp.52.6.724 · DOI · Paper page
- 10.1136/jnnp.49.10.1182 · DOI · Paper page
- Celesia GG, 1972, Psychiatric disturbances in Parkinson's disease, Dis Nervous System, 33, 577
- 10.1002/cne.902870308 · DOI · Paper page
- 10.1016/S0024-3205(97)00409-8 · DOI
- 10.1093/brain/114.5.2095 · DOI · Paper page
- 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H · doi:10.1002/(sici)1520-6394(2000)11:2<58::aid-da2>3.0.co;2-h
- Cote L, 1999, Depression. Impact and management by the patient and family, Neurology, 52, S7
- 10.1176/ajp.149.4.443 · DOI · Paper page
- 10.1002/(SICI)1099-1166(199909)14:9<711::AID-GPS4>3.0.CO;2-1 · doi:10.1002/(sici)1099-1166(199909)14:9<711::aid-gps4>3.0.co;2-1
- 10.1093/brain/122.8.1437 · DOI · Paper page
- Doder M, 2000, Brain serotonin 1A receptors in Parkinson's disease with and without depression measured by positron emission tomography with 11C‐WAY 100635, Movement Disorders, 15, 213
- 10.1001/archneur.1992.00530270125028 · DOI · Paper page
- Douyon R, 1990, ECT and Parkinson's disease revisited: a ‘naturalistic’ study, Am J Psychiatry, 146, 1451
- 10.1159/000117534 · DOI
- 10.2165/00003495-199957040-00005 · DOI · Paper page
- 10.1177/089198879000300102 · DOI · Paper page
- 10.1097/00004714-199908000-00008 · DOI · Paper page
- 10.1136/jnnp.68.4.423 · DOI · Paper page
- 10.1002/mds.10010 · DOI · Paper page
- 10.1212/WNL.34.8.1092 · DOI · Paper page
- 10.1136/jnnp.49.4.381 · DOI · Paper page
- 10.1176/ajp.151.7.1010 · DOI · Paper page
- 10.1176/jnp.4.3.257 · DOI · Paper page
- 10.1007/s004150070101 · DOI
- 10.1055/s-2007-979191 · DOI · Paper page
- 10.1136/jnnp.51.6.855 · DOI · Paper page
- 10.1212/WNL.54.8.1596 · DOI · Paper page
- 10.1016/S0165-0327(99)00199-8 · DOI
- 10.1212/WNL.40.10.1529 · DOI · Paper page
- 10.1016/0165-0327(83)90006-X · DOI
- 10.1136/jnnp.66.4.431 · DOI · Paper page
- 10.1176/jnp.7.3.281 · DOI · Paper page
- 10.1007/BF00314109 · DOI
- 10.1007/BF01271258 · DOI
- 10.1002/1531-8257(200003)15:2<216::AID-MDS1003>3.0.CO;2-# · DOI · Paper page
- 10.1111/j.1600-0404.1969.tb01224.x · DOI · Paper page
- 10.1177/026988119801200212 · DOI · Paper page
- 10.1176/ajp.132.3.283 · DOI
- 10.1002/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L · DOI · Paper page
- 10.1002/1531-8257(200011)15:6<1221::AID-MDS1024>3.0.CO;2-H · DOI · Paper page
- Leentjens AFG, 1999, Mental Dysfunction in Parkinson's Disease, 272
- 10.4088/JCP.v61n1111a · DOI
- Leonard BE, 1999, Mental Dysfunction in Parkinson's Disease, 248
- 10.1136/jnnp.51.11.1401 · DOI · Paper page
- 10.1136/jnnp.64.2.178 · DOI · Paper page
- 10.1016/S0022-510X(98)00318-9 · DOI
- 10.1002/(SICI)1097-4547(19990915)57:6<935::AID-JNR19>3.0.CO;2-8 · DOI · Paper page
- 10.1017/S1041610201007608 · DOI · Paper page
- 10.1212/WNL.34.5.642 · DOI · Paper page
- 10.1212/WNL.31.6.645 · DOI · Paper page
- 10.1002/mds.870030308 · DOI · Paper page
- 10.1093/ageing/28.1.35 · DOI · Paper page
- 10.1192/bjp.179.42.s1 · DOI
- 10.1177/089198879901200202 · DOI · Paper page
- 10.1016/0006-3223(93)90237-8 · DOI · Paper page
- 10.1002/(SICI)1099-1166(199603)11:3<263::AID-GPS316>3.0.CO;2-P · doi:10.1002/(sici)1099-1166(199603)11:3<263::aid-gps316>3.0.co;2-p
- 10.1176/jnp.10.2.187 · DOI · Paper page
- 10.1002/mds.870100325 · DOI
- 10.1038/sj.mp.4000849 · DOI
- 10.1017/S0033291700000702 · DOI · Paper page
- 10.1055/s-2007-979504 · DOI
- Poewe W, 1999, Depression in Parkinson's disease: impediments to recognition and treatment options, Neurology, 52, S2
- Rektorova I, 2001, Depression in Parkinson's disease: an eight‐month, randomised, open‐label, national, multi‐centre comparative study of pramipexole and pergolide, Parkinsonism Related Disorders, 7, S68
- 10.1212/WNL.49.4.1168 · DOI · Paper page
- 10.1212/WNL.48.4.1070 · DOI · Paper page
- 10.1002/ana.410260107 · DOI · Paper page
- Rodriguez‐Oroz MC, 2000, Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease, Neurology, 55, S45
- 10.1007/s002130000485 · DOI
- 10.1002/mds.10006 · doi:10.1002/mds.10006
- 10.1001/archpsyc.57.2.174 · DOI · Paper page
- 10.1136/jnnp.69.3.308 · DOI · Paper page
- 10.1002/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5 · DOI · Paper page
- 10.1002/mds.1099 · DOI · Paper page
- 10.3109/10401230009147102 · DOI
- 10.1212/WNL.39.11.1441 · DOI · Paper page
- 10.1136/jnnp.53.7.597 · DOI · Paper page
- 10.1136/jnnp.55.5.377 · DOI · Paper page
- 10.1002/mds.870130109 · DOI · Paper page
- 10.1097/00005053-199001000-00005 · DOI · Paper page
- 10.1136/jnnp.53.10.869 · DOI · Paper page
- 10.1212/WNL.43.9.1690 · DOI · Paper page
- 10.1136/bmj.2.5452.33 · DOI · Paper page
- 10.1001/archneur.1996.00550020087019 · DOI · Paper page
- 10.1001/archneur.1997.00550170097020 · DOI · Paper page
- 10.1093/brain/109.2.279 · DOI · Paper page
- 10.1002/1531-8257(200009)15:5<986::AID-MDS1034>3.0.CO;2-I · DOI · Paper page
- 10.1523/JNEUROSCI.20-15-05581.2000 · DOI · Paper page
- 10.1001/archneur.1988.00520290025008 · DOI · Paper page
- 10.1001/archneur.1995.00540360042014 · DOI · Paper page
- 10.1055/s-2007-1019537 · DOI
- 10.1136/jnnp.30.4.368 · DOI · Paper page
- 10.1007/s002130100746 · DOI · Paper page
Cited by
Neurological diseases and pain
Borsook, D. (2012) · Brain · doi:10.1093/brain/awr271 · Cited by 278
Clinical characteristics in early Parkinson's disease in a central California population‐based study
Kang, G. A., Bronstein, J. M., Masterman, D. L., Redelings, M., Crum, J. A., & Ritz, B. (2005) · Movement Disorders · doi:10.1002/mds.20513 · Cited by 266
HCN2 channels in the ventral tegmental area regulate behavioral responses to chronic stress
Zhong, P., Vickstrom, C. R., Liu, X., Hu, Y., Yu, L., Yu, H.-G., & Liu, Q.-S. (2018) · eLife · doi:10.7554/elife.32420 · Cited by 99
“%) of comorbid depression in patients with Parkinson’s disease (Burn, 2002), which is characterized by the degeneration of midbrain dopaminergic neurons (Alberico et al., 2015).”
BackgroundKhedr, E. M., Abdelrahman, A. A., Elserogy, Y., Zaki, A. F., & Gamea, A. (2020) · The Egyptian Journal of Neurology, Psychiatry and Neurosurgery · doi:10.1186/s41983-020-00253-5 · Cited by 61
Clare, L., Teale, J. C., Toms, G., Kudlicka, A., Evans, I., Abrahams, S., Goldstein, L. H., Hindle, J. V., Ho, A. K., Jahanshahi, M., et al. (2019) · NeuroRehabilitation · doi:10.3233/nre-172353 · Cited by 37
Metadata
- Authors
- Burn, D. J.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2002-11
- Volume
- 9
- Issue
- s3
- Pages
- 44-54
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W1979979047
- Cited by
- 94
- References
- 8
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Depression in Parkinson's disease. https://app.cochat.ai/papers/10.1046/j.1468-1331.9.s3.6.x
- The paper
- Burn, D. J. (2002). Depression in Parkinson's disease. European Journal of Neurology. https://doi.org/10.1046/j.1468-1331.9.s3.6.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.